Illinois patients may not be aware that as many as 75 percent of breast cancer misdiagnoses might result from a misinterpreted cancer biopsy. The Journal of the American Medical Association published a study that involved 100 pathologists who were asked to provide their diagnostic opinion on different breast cancer biopsies. Their findings were reviewed by some of the top doctors in the medical field, and a significant number of misdiagnoses were found.
The study sparked a major change in the medical community, removing breast cancer biopsies as the standard for diagnosing breast cancer. Such misdiagnoses often result in under- or over-treatment for patients with breast cancer. Experts such as the author of the study urge women to pursue a second opinion before consenting to any actual cancer treatment in order to prevent such problems.
One of the most serious consequences of misdiagnosis is that women who do have breast cancer often go undiagnosed. Experts advise seeking a second opinion in such cases to lessen the chance of a false negative diagnosis, which could allow the cancer to spread further. Likewise, women who receive over-treatment as the result of misdiagnosis may face unnecessary and often physically difficult treatment for something they do not actually have.
Illinois patients who have been the victim of misdiagnosis may be eligible to file a medical malpractice lawsuit. A malpractice lawsuit may be filed for standard misdiagnosis or delayed diagnosis, which contributed to the progression of the disease. Such lawsuits hinge on the evidence that the diagnostician acted as a negligent physician and failed to diagnose the condition they should have reasonably arrived at through standard practice. In these cases, wrongly diagnosed patients may be eligible for compensation for medical expenses, lost wages and pain and suffering.